Extracellular modulators of Wnt signalling

Current Opinion in Structural Biology

Volumn 29, Issue , 2014, Pages 77-84

  Malinauskas, Tomas ^a   Jones, E Yvonne ^b  

^a Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DICKKOPF 1 PROTEIN; FRIZZLED PROTEIN; GLYCOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 6; NORRIN; PROTEOHEPARAN SULFATE; SCLEROSTIN; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; WNT PROTEIN; WNT3A PROTEIN; WNT8 PROTEIN; WNTD PROTEIN; CYSTEINE; DNA BINDING PROTEIN; PROTEIN BINDING; SCLEROPROTEIN; UBIQUITIN PROTEIN LIGASE;

AMINO ACID SEQUENCE; CELL SURFACE; COMPLEX FORMATION; EXTRACELLULAR SPACE; NONHUMAN; PROTEIN CARBOHYDRATE INTERACTION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; BINDING SITE; CHEMISTRY; HUMAN; PROTEIN CONFORMATION; WNT SIGNALING PATHWAY;

ANIMALS; BINDING SITES; CYSTEINE; DNA-BINDING PROTEINS; EXTRACELLULAR MATRIX PROTEINS; FRIZZLED RECEPTORS; HUMANS; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-5; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-6; PROTEIN BINDING; PROTEIN CONFORMATION; UBIQUITIN-PROTEIN LIGASES; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84908346570     PISSN: 0959440X     EISSN: 1879033X     Source Type: Journal    
DOI: 10.1016/j.sbi.2014.10.003     Document Type: Review

References (46)

1. Clevers H., Nusse R. Wnt/β-catenin signaling and disease. Cell 2012, 149:1192-1205.
2. Holland J.D., Klaus A., Garratt A.N., Birchmeier W. Wnt signaling in stem and cancer stem cells. Curr Opin Cell Biol 2013, 25:254-264.
3. Polakis P. Drugging Wnt signalling in cancer. EMBO J 2012, 31:2737-2746.
4. MacDonald B.T., Tamai K., He X. Wnt/β-catenin signaling: components, mechanisms, and diseases. Dev Cell 2009, 17:9-26.
5. Niehrs C. The complex world of WNT receptor signalling. Nat Rev Mol Cell Biol 2012, 13:767-779.
6. Zhang X., Abreu J.G., Yokota C., MacDonald B.T., Singh S., Coburn K.L., Cheong S.M., Zhang M.M., Ye Q.Z., Hang H.C., et al. Tiki1 is required for head formation via Wnt cleavage-oxidation and inactivation. Cell 2012, 149:1565-1577.
7. Bazan J.F., MacDonald B.T., He X. The TIKI/TraB/PrgY family: a common protease fold for cell signaling from bacteria to metazoa?. Dev Cell 2013, 25:225-227.
8. Sanchez-Pulido L., Ponting C.P. Tiki, at the head of a new superfamily of enzymes. Bioinformatics 2013, 29:2371-2374.
9. Dann C.E., Hsieh J.C., Rattner A., Sharma D., Nathans J., Leahy D.J. Insights into Wnt binding and signalling from the structures of two Frizzled cysteine-rich domains. Nature 2001, 412:86-90.
10. Janda C.Y., Waghray D., Levin A.M., Thomas C., Garcia K.C. Structural basis of Wnt recognition by Frizzled. Science 2012, 337:59-64.
11. Bazan J.F., Janda C.Y., Garcia K.C. Structural architecture and functional evolution of Wnts. Dev Cell 2012, 23:227-232.
12. Chu M.L., Ahn V.E., Choi H.J., Daniels D.L., Nusse R., Weis W.I. Structural studies of Wnts and identification of an LRP6 binding site. Structure 2013, 21:1235-1242.
13. Xu Q., Wang Y., Dabdoub A., Smallwood P.M., Williams J., Woods C., Kelley M.W., Jiang L., Tasman W., Zhang K., et al. Vascular development in the retina and inner ear: control by Norrin and Frizzled-4, a high-affinity ligand-receptor pair. Cell 2004, 116:883-895.
14. Ke J., Harikumar K.G., Erice C., Chen C., Gu X., Wang L., Parker N., Cheng Z., Xu W., Williams B.O., et al. Structure and function of Norrin in assembly and activation of a Frizzled 4-Lrp5/6 complex. Genes Dev 2013, 27:2305-2319.
15. Bovolenta P., Esteve P., Ruiz J.M., Cisneros E., Lopez-Rios J. Beyond Wnt inhibition: new functions of secreted Frizzled-related proteins in development and disease. J Cell Sci 2008, 121:737-746.
16. Malinauskas T., Aricescu A.R., Lu W., Siebold C., Jones E.Y. Modular mechanism of Wnt signaling inhibition by Wnt inhibitory factor 1. Nat Struct Mol Biol 2011, 18:886-893.
17. Liepinsh E., Bányai L., Patthy L., Otting G. NMR structure of the WIF domain of the human Wnt-inhibitory factor-1. J Mol Biol 2006, 357:942-950.
18. Malinauskas T. Docking of fatty acids into the WIF domain of the human Wnt inhibitory factor-1. Lipids 2008, 43:227-230.
19. Bazan J.F., de Sauvage F.J. Structural ties between cholesterol transport and morphogen signaling. Cell 2009, 138:1055-1056.
20. Sakane H., Yamamoto H., Matsumoto S., Sato A., Kikuchi A. Localization of glypican-4 in different membrane microdomains is involved in the regulation of Wnt signaling. J Cell Sci 2012, 125:449-460.
21. Capurro M., Martin T., Shi W., Filmus J. Glypican-3 binds to Frizzled and plays a direct role in the stimulation of canonical Wnt signaling. J Cell Sci 2014, 127:1565-1575.
22. Chen L., Wang K., Shao Y., Huang J., Li X., Shan J., Wu D., Zheng J.J. Structural insight into the mechanisms of Wnt signaling antagonism by Dkk. J Biol Chem 2008, 283:23364-23370.
23. Ahn V.E., Chu M.L., Choi H.J., Tran D., Abo A., Weis W.I. Structural basis of Wnt signaling inhibition by Dickkopf binding to LRP5/6. Dev Cell 2011, 21:862-873.
24. Cheng Z., Biechele T., Wei Z., Morrone S., Moon R.T., Wang L., Xu W. Crystal structures of the extracellular domain of LRP6 and its complex with DKK1. Nat Struct Mol Biol 2011, 18:1204-1210.
25. Veverka V., Henry A.J., Slocombe P.M., Ventom A., Mulloy B., Muskett F.W., Muzylak M., Greenslade K., Moore A., Zhang L., et al. Characterization of the structural features and interactions of sclerostin: molecular insight into a key regulator of Wnt-mediated bone formation. J Biol Chem 2009, 284:10890-10900.
26. Weidauer S.E., Schmieder P., Beerbaum M., Schmitz W., Oschkinat H., Mueller T.D. NMR structure of the Wnt modulator protein Sclerostin. Biochem Biophys Res Commun 2009, 380:160-165.
27. Bourhis E., Tam C., Franke Y., Bazan J.F., Ernst J., Hwang J., Costa M., Cochran A.G., Hannoush R.N. Reconstitution of a frizzled8.Wnt3a.LRP6 signaling complex reveals multiple Wnt and Dkk1 binding sites on LRP6. J Biol Chem 2010, 285:9172-9179.
28. Bourhis E., Wang W., Tam C., Hwang J., Zhang Y., Spittler D., Huang O.W., Gong Y., Estevez A., Zilberleyb I., et al. Wnt antagonists bind through a short peptide to the first β-propeller domain of LRP5/6. Structure 2011, 19:1433-1442.
29. Chen S., Bubeck D., MacDonald B.T., Liang W.X., Mao J.H., Malinauskas T., Llorca O., Aricescu A.R., Siebold C., He X., et al. Structural and functional studies of LRP6 ectodomain reveal a platform for Wnt signaling. Dev Cell 2011, 21:848-861.
30. Holdsworth G., Slocombe P., Doyle C., Sweeney B., Veverka V., Le Riche K., Franklin R.J., Compson J., Brookings D., Turner J., et al. Characterization of the interaction of sclerostin with the low density lipoprotein receptor-related protein (LRP) family of Wnt co-receptors. J Biol Chem 2012, 287:26464-26477.
31. Zhao Y., Malinauskas T., Harlos K., Jones E.Y. Structural insights into the inhibition of Wnt signaling by cancer antigen 5T4/Wnt-activated inhibitory factor 1. Structure 2014, 22:612-620.
32. Hao H.X., Xie Y., Zhang Y., Charlat O., Oster E., Avello M., Lei H., Mickanin C., Liu D., Ruffner H., et al. ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner. Nature 2012, 485:195-200.
33. Koo B.K., Spit M., Jordens I., Low T.Y., Stange D.E., van de Wetering M., van Es J.H., Mohammed S., Heck A.J., Maurice M.M., Clevers H. Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors. Nature 2012, 488:665-669.
34. Moffat L.L., Robinson R.E., Bakoulis A., Clark S.G. The conserved transmembrane RING finger protein PLR-1 downregulates Wnt signaling by reducing Frizzled, Ror and Ryk cell-surface levels in C. elegans. Development 2014, 141:617-628.
35. Chen P.H., Chen X., Lin Z., Fang D., He X. The structural basis of R-spondin recognition by LGR5 and RNF43. Genes Dev 2013, 27:1345-1350.
36. Zebisch M., Xu Y., Krastev C., MacDonald B.T., Chen M., Gilbert R.J.C., He X., Jones E.Y. Structural and molecular basis of ZNRF3/RNF43 transmembrane ubiquitin ligase inhibition by Wnt agonist R-spondin. Nat Commun 2013, 4:2787.
37. Peng W.C., de Lau W., Madoori P.K., Forneris F., Granneman J.C., Clevers H., Gros P. Structures of Wnt-antagonist ZNRF3 and its complex with R-spondin 1 and implications for signaling. PLoS ONE 2013, 8:e83110.
38. de Lau W.B., Snel B., Clevers H.C. The R-spondin protein family. Genome Biol 2012, 13:242.
39. Carmon K.S., Gong X., Lin Q., Thomas A., Liu Q. R-spondins function as ligands of the orphan receptors LGR4 and LGR5 to regulate Wnt/beta-catenin signaling. Proc Natl Acad Sci USA 2011, 108:11452-11457.
40. Carmon K.S., Lin Q., Gong X., Thomas A., Liu Q. LGR5 interacts and cointernalizes with Wnt receptors to modulate Wnt/β-catenin signaling. Mol Cell Biol 2012, 32:2054-2064.
41. de Lau W., Barker N., Low T.Y., Koo B.K., Li V.S., Teunissen H., Kujala P., Haegebarth A., Peters P.J., van de Wetering M., et al. Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling. Nature 2011, 476:293-297.
42. Glinka A., Dolde C., Kirsch N., Huang Y.L., Kazanskaya O., Ingelfinger D., Boutros M., Cruciat C.M., Niehrs C. LGR4 and LGR5 are R-spondin receptors mediating Wnt/beta-catenin and Wnt/PCP signalling. EMBO Rep 2011, 12:1055-1061.
43. Ruffner H., Sprunger J., Charlat O., Leighton-Davies J., Grosshans B., Salathe A., Zietzling S., Beck V., Therier M., Isken A., et al. R-spondin potentiates Wnt/β-catenin signaling through orphan receptors LGR4 and LGR5. PLoS ONE 2012, 7:e40976.
44. Wang D., Huang B., Zhang S., Yu X., Wu W., Wang X. Structural basis for R-spondin recognition by LGR4/5/6 receptors. Genes Dev 2013, 27:1339-1344.
45. Peng W.C., de Lau W., Forneris F., Granneman J.C., Huch M., Clevers H., Gros P. Structure of stem cell growth factor R-spondin 1 in complex with the ectodomain of its receptor LGR5. Cell Rep 2013, 3:1885-1892.
46. Xu K., Xu Y., Rajashankar K.R., Robev D., Nikolov D.B. Crystal structures of Lgr4 and its complex with R-spondin1. Structure 2013, 21:1683-1689.